Transcatheter aortic valve implantation: where are we now?
Future Cardiol
; 13(6): 551-566, 2017 11.
Article
em En
| MEDLINE
| ID: mdl-29064293
ABSTRACT
Transcatheter aortic valve implantation (TAVI) was first used in clinical practice in 2002. Since 2002, there has been a rapid increase in TAVI activity in patients with symptomatic severe aortic stenosis. This has been supported by systematic randomized data comparing TAVI against the gold standard treatment for the last 50 years' surgical aortic valve replacement. TAVI is now currently a recommended therapeutic intervention in the treatment of severe aortic stenosis patients who are deemed either high risk or inoperable. The indications for TAVI continue to expand. Within this review we will focus on the current guidelines for TAVI, the evidence for it, the complications of TAVI, postprocedure care, the technology available to clinicians now and finally the future perspectives for TAVI.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Estenose da Valva Aórtica
/
Guias de Prática Clínica como Assunto
/
Substituição da Valva Aórtica Transcateter
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article